Cerebral Subcortical Small Vessel Disease in Subjects With Pathologically Confirmed Alzheimer Disease A Clinicopathologic Study in the Oxford Project to Investigate Memory and Ageing (OPTIMA)

被引:49
作者
Esiri, Margaret M. [1 ,2 ]
Joachim, Catharine [1 ,2 ]
Sloan, Carolyn [1 ,2 ]
Christie, Sharon [3 ]
Agacinski, Grzegorz [3 ]
Bridges, Leslie R. [5 ]
Wilcock, Gordon K. [3 ]
Smith, A. David [4 ]
机构
[1] John Radcliffe Hosp, Dept Neuropathol, Oxford OX3 9DU, England
[2] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
[3] Univ Oxford, Nuffield Dept Med, Oxford, England
[4] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
[5] Univ London, St Georges Hosp, Dept Pathol, London WC1E 7HU, England
关键词
subcortical small vessel disease; neuropathology; Alzheimer disease; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; COGNITIVE FUNCTION; VASCULAR DEMENTIA; HOMOCYSTEINE; LESIONS; DECLINE; AGE;
D O I
10.1097/WAD.0b013e31829b72f1
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
The understanding of how cerebrovascular disease (CVD) contributes to dementia is hampered by a lack of agreed and validated pathologic methods to accord weight to the contribution of different aspects of CVD to dementia. A previous study from the Oxford Project to Investigate Memory and Ageing (OPTIMA) validated a scheme for assessing the contribution of subcortical small vessel disease (SVD) toward dementia in the elderly by showing a significant inverse relationship between the severity of SVD and cognition in subjects without any other dementia pathology using this method. In the present paper, the method has been used to assess severity of SVD in 161 cases of neuropathologically confirmed Alzheimer disease. The results showed there was no relationship between the SVD score and cognitive scores acquired in the last 2 years of life. SVD scores were significantly related to age (P < 0.0017) and were slightly but significantly higher in females than males (P < 0.049). SVD scores were not related to blood pressure at entry to OPTIMA and were significantly lower when compared with the cohort of OPTIMA cases with only CVD (mean 5.06 +/- 1.85 vs. 5.9 +/- 2.67; P < 0.0065). We conclude that when Alzheimer disease pathology is present in elderly subjects, it overwhelms the modest contribution that SVD makes to cognitive impairment.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 36 条
[1]
The projected effect of risk factor reduction on Alzheimer's disease prevalence [J].
Barnes, Deborah E. ;
Yaffe, Kristine .
LANCET NEUROLOGY, 2011, 10 (09) :819-828
[2]
NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[3]
Chui Helena Chang, 2006, Alzheimers Dement, V2, P185, DOI 10.1016/j.jalz.2006.03.003
[4]
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics [J].
de la Torre, JC .
LANCET NEUROLOGY, 2004, 3 (03) :184-190
[5]
Homocysteine and cognitive performance in the framingham offspring study: Age is important [J].
Elias, MF ;
Sullivan, LM ;
D'Agostino, RB ;
Elias, PK ;
Jacques, PF ;
Selhub, J ;
Seshadri, S ;
Au, R ;
Beiser, A ;
Wolf, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (07) :644-653
[6]
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease [J].
Esiri, MM ;
Nagy, Z ;
Smith, MZ ;
Barnetson, L ;
Smith, AD .
LANCET, 1999, 354 (9182) :919-920
[7]
Neuropathological assessment of the lesions of significance in vascular dementia [J].
Esiri, MM ;
Wilcock, GK ;
Morris, JH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (06) :749-753
[8]
THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .10. NEUROPATHOLOGY CONFIRMATION OF THE CLINICAL-DIAGNOSIS OF ALZHEIMERS-DISEASE [J].
GEARING, M ;
MIRRA, SS ;
HEDREEN, JC ;
SUMI, SM ;
HANSEN, LA ;
HEYMAN, A .
NEUROLOGY, 1995, 45 (03) :461-466
[9]
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Gorelick, Philip B. ;
Scuteri, Angelo ;
Black, Sandra E. ;
DeCarli, Charles ;
Greenberg, Steven M. ;
Iadecola, Costantino ;
Launer, Lenore J. ;
Laurent, Stephane ;
Lopez, Oscar L. ;
Nyenhuis, David ;
Petersen, Ronald C. ;
Schneider, Julie A. ;
Tzourio, Christophe ;
Arnett, Donna K. ;
Bennett, David A. ;
Chui, Helena C. ;
Higashida, Randall T. ;
Lindquist, Ruth ;
Nilsson, Peter M. ;
Roman, Gustavo C. ;
Sellke, Frank W. ;
Seshadri, Sudha .
STROKE, 2011, 42 (09) :2672-2713
[10]
Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease [J].
Hogervorst, E ;
Ribeiro, HM ;
Molyneux, A ;
Budge, M ;
Smith, D .
ARCHIVES OF NEUROLOGY, 2002, 59 (05) :787-793